PATENT CLAIM ANALYSIS

Application Number: 15979041
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "402000"]

Abstract:
The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.

Claim (Index 40):
The method of  claim 39  wherein the drug therapy comprises the administration of bisantrene and wherein the post-treatment management is selected from the group consisting of:\n (a) a therapy associated with pain management; \n (b) nutritional support; \n (c) administration of an anti-emetic; \n (d) an anti-nausea therapy; \n (e) administration of an anti-inflammatory agent; \n (f) administration of an antipyretic agent; \n (g) administration of an immune stimulant; and \n (h) administration of a growth factor.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.31579
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14907728', '14907729', '13817096', '14753911', '14245738']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7896684078702888
- 35 USC 102 Novelty (BERT): 0.5348559219838066
- Combined Prediction Score: 0.7641871592816406
- Mean Citation Score: 267.787678
- Max Citation Score: 348.62634
- Similarity Product: 228.9114206314016

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test